Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

2.

Study links persistent fatigue in breast cancer survivors to increased inflammation

3.

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

4.

How a California Oncologist Making $850k Spends Money

5.

Guideline on management of early-stage non-small cell lung cancer released


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot